scholarly journals In vivo evaluation of a hollow fiber liver assist device

Hepatology ◽  
1995 ◽  
Vol 21 (2) ◽  
pp. 460-469 ◽  
Author(s):  
Hugo O. Jauregui ◽  
Claudy J-P. Mullon ◽  
Donna Trenkler ◽  
Sharda Naik ◽  
Henry Santangini ◽  
...  
Keyword(s):  
Hollow Fiber ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Liver Assist Device

In Vivo Evaluation of a Pneumatic Extracorporeal Ventricular Assist Device for up to 90 Day Support

ASAIO Journal ◽  
2016 ◽  
Vol 62 (6) ◽  
pp. 697-703 ◽  
Author(s):  
Jeff L. Conger ◽  
Brian W. Grace ◽  
Kelsey L. Van Noy ◽  
Kelly M. Handy ◽  
Gil G. Costas ◽  
...  
Keyword(s):  
Ventricular Assist Device ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Ventricular Assist

In Vivo Evaluation of an Intrathoracic Ventricular Assist Device

ASAIO Journal ◽  
1999 ◽  
Vol 45 (3) ◽  
pp. 123-126 ◽  
Author(s):  
PAUL HENDRY ◽  
ROY G. MASTERS ◽  
MOHEB IBRAHIM ◽  
MICHAEL BOURKE ◽  
MARILYN KEANEY ◽  
...  
Keyword(s):  
Ventricular Assist Device ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Ventricular Assist

Multi-Purpose Mechanical Circulatory Device

1997 ◽  
Vol 20 (4) ◽  
pp. 217-221 ◽  
Author(s):  
T.V. Mussivand ◽  
P.J. Hendry ◽  
R.G. Masters ◽  
W.J. Keon
Keyword(s):  
Information Transfer ◽  
Hospital Setting ◽  
Left Ventricular ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Left Hemithorax ◽  
Ventricular Assist ◽  
Ventricular Support

A mechanical circulatory assist device for long term use outside the hospital setting has been developed. The device can be used for left, right or bi-ventricular support, and several of the developed technologies are applicable for total artificial hearts and non-pulsatile flow systems. The totally implantable device is principally designed for left ventricular support with implantation in the left hemithorax. The system utilizes transcutaneous energy and information transfer sub-systems, and has no percutaneous connections. In vitro durability testing has been conducted for periods from 1-4 years. Bovine experiments have been conducted with sustained circulation for periods form 1.5 to 96 hours. The in vitro and in vivo evaluation to date has demonstrated that the system can function effectively as a totally implantable ventricular assist device. The transcutaneous energy and information transfer sub-systems provided the ability to power, monitor and control the device, without the need for percutaneous connections. Design optimization and chronic in vivo evaluation is planned

Development of an Axial Flow Ventricular Assist Device: In Vitro and In Vivo Evaluation

1995 ◽  
Vol 19 (7) ◽  
pp. 653-659 ◽  
Author(s):  
Kazumi Mizuguchi ◽  
George Damm ◽  
Robert Benkowsky ◽  
Greg Aber ◽  
Jim Bacak ◽  
...  
Keyword(s):  
Ventricular Assist Device ◽  
Axial Flow ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Ventricular Assist

In Vivo Evaluation of the Miniaturized Gyro Centrifugal Pump as an Implantable Ventricular Assist Device

1998 ◽  
Vol 22 (8) ◽  
pp. 713-720 ◽  
Author(s):  
Yoshiyuki Takami ◽  
Goro Otsuka ◽  
Jurgen Mueller ◽  
Yohichi Sugita ◽  
Kin‐ichi Nakata ◽  
...  
Keyword(s):  
Centrifugal Pump ◽  
Ventricular Assist Device ◽  
Assist Device ◽  
In Vivo Evaluation ◽  
Ventricular Assist

IN VITRO AND IN VIVO EVALUATION OF A MODIFIED ASSIST DEVICE TYPE-5 FOR PRECLINICAL EVALUATION

ASAIO Journal ◽  
1996 ◽  
Vol 42 (2) ◽  
pp. 33
Author(s):  
K. Innanishi ◽  
K. Imachi ◽  
Y. Abe ◽  
H. Yoshito ◽  
T. Chinzei ◽  
...  
Keyword(s):  
Assist Device ◽  
In Vivo Evaluation ◽  
Preclinical Evaluation ◽  
Device Type
Sign in / Sign up

Export Citation Format

Share Document